GlobeNewsWire
17 Jul 2026, 16:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Insulet Corporation is facing a securities fraud class action lawsuit alleging that it misled investors and failed to disclose defective manufacturing controls. — Class action lawsuits for securities fraud create significant legal liability and can damage investor confidence in management's transparency.
-0.60Insulet issued two voluntary medical device corrections for Omnipod products between March and May 2026 due to manufacturing issues including potential insulin under-delivery. — Recurring product recalls for critical medical devices suggest systemic quality control issues and pose regulatory and safety risks.
-0.50Which stocks this story touches
The company is facing a class action securities fraud lawsuit following multiple medical device recalls and significant stock price declines.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
7h ago
